Bioactive constituents of Salvia przewalskii and the molecular mechanism of its antihypoxia effects determined using quantitative proteomics

por Wang, Yafeng, Duo, Delong, Yan, Yingjun, He, Rongyue, Wang, Shengbiao, Wang, Aixia, Wu, Xinan
Publicado 2020

Allele-specific activation, enzyme kinetics, and inhibitor sensitivities of EGFR exon 19 deletion mutations in lung cancer

por Brown, Benjamin P., Zhang, Yun-Kai, Kim, Soyeon, Finneran, Patrick, Yan, Yingjun, Du, Zhenfang, Kim, Jiyoon, Hartzler, Abigail Leigh, LeNoue-Newton, Michele L., Smith, Adam W., Meiler, Jens, Lovly, Christine M.
Publicado 2022

Blood-Based Surveillance Monitoring of Circulating Tumor DNA From Patients With SCLC Detects Disease Relapse and Predicts Death in Patients With Limited-Stage Disease

por Iams, Wade T., Kopparapu, Prasad R., Yan, Yingjun, Muterspaugh, Anel, Zhao, Zhiguo, Chen, Heidi, Cann, Christopher, York, Sally, Horn, Leora, Ancell, Kristin, Wyman, Kenneth, Bertucci, Caterina, Shaffer, Tristan, Hodsdon, Lauren A., Garg, Kavita, Hosseini, Seyed Ali, Lim, Lee P., Lovly, Christine M.
Publicado 2020

Structure–function analysis of oncogenic EGFR Kinase Domain Duplication reveals insights into activation and a potential approach for therapeutic targeting

por Du, Zhenfang, Brown, Benjamin P., Kim, Soyeon, Ferguson, Donna, Pavlick, Dean C., Jayakumaran, Gowtham, Benayed, Ryma, Gallant, Jean-Nicolas, Zhang, Yun-Kai, Yan, Yingjun, Red-Brewer, Monica, Ali, Siraj M., Schrock, Alexa B., Zehir, Ahmet, Ladanyi, Marc, Smith, Adam W., Meiler, Jens, Lovly, Christine M.
Publicado 2021

Circulating Tumor DNA as a Biomarker of Radiographic Tumor Burden in SCLC

por Smith, Jarrod T., Balar, Aneri, Lakhani, Dhairya A., Kluwe, Christien, Zhao, Zhiguo, Kopparapu, Prasad, Almodovar, Karinna, Muterspaugh, Anel, Yan, Yingjun, York, Sally, Horn, Leora, Antic, Sanja, Bertucci, Caterina, Shaffer, Tristan, Hodsdon, Lauren, Garg, Kavita, Hosseini, Seyed Ali, Lim, Lee, Osmundson, Evan, Massion, Pierre P., Lovly, Christine M., Iams, Wade
Publicado 2020

Rationale for co-targeting IGF-1R and ALK in ALK fusion positive lung cancer

por Lovly, Christine M., McDonald, Nerina T., Chen, Heidi, Ortiz-Cuaran, Sandra, Heukamp, Lukas C., Yan, Yingjun, Florin, Alexandra, Ozretić, Luka, Lim, Diana, Wang, Lu, Chen, Zhao, Chen, Xi, Lu, Pengcheng, Paik, Paul K., Shen, Ronglai, Jin, Hailing, Buettner, Reinhard, Ansén, Sascha, Perner, Sven, Brockmann, Michael, Bos, Marc, Wolf, Jürgen, Gardizi, Masyar, Wright, Gavin M., Solomon, Benjamin, Russell, Prudence A., Rogers, Toni-Maree, Suehara, Yoshiyuki, Red-Brewer, Monica, Tieu, Rudy, de Stanchina, Elisa, Wang, Qingguo, Zhao, Zhongming, Johnson, David H., Horn, Leora, Wong, Kwok-Kin, Thomas, Roman K., Ladanyi, Marc, Pao, William
Publicado 2014